ZNF32 expression was associated with a 1.97-fold higher risk of death, whereas other parameters (including sex, tumor stage and grade, and Ki67 positivity) were not significantly related to the risk of death (Figure 6d). The gene discussed is MKI67; the disease is neoplasm.